Tumor uptake in glioblastoma multiforme after IV injection of [¹⁷⁷Lu]Lu-PSMA-617

Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1605-1606. doi: 10.1007/s00259-020-04715-z. Epub 2020 Feb 10.

Authors

Jolanta Kunikowska¹, Ingeborga Charzyńska², Radosław Kuliński², Dariusz Pawlak³, Michał Maurin³, Leszek Królicki²

Affiliations

¹ Department of Nuclear Medicine, Medical University of Warsaw, ul. Banacha 1 a, 02-097, Warsaw, Poland. jolanta.kunikowska@wum.edu.pl.
² Department of Nuclear Medicine, Medical University of Warsaw, ul. Banacha 1 a, 02-097, Warsaw, Poland.
³ Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock-Świerk, Poland.

No abstract available

MeSH terms

Dipeptides
Glioblastoma* / diagnostic imaging
Heterocyclic Compounds, 1-Ring
Humans
Prostate-Specific Antigen

Substances

Dipeptides
Heterocyclic Compounds, 1-Ring
PSMA-617
Prostate-Specific Antigen